Correlation Between Inari Medical and MaxCyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inari Medical and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inari Medical and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inari Medical and MaxCyte, you can compare the effects of market volatilities on Inari Medical and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inari Medical with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inari Medical and MaxCyte.

Diversification Opportunities for Inari Medical and MaxCyte

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Inari and MaxCyte is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Inari Medical and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Inari Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inari Medical are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Inari Medical i.e., Inari Medical and MaxCyte go up and down completely randomly.

Pair Corralation between Inari Medical and MaxCyte

Given the investment horizon of 90 days Inari Medical is expected to generate 0.92 times more return on investment than MaxCyte. However, Inari Medical is 1.08 times less risky than MaxCyte. It trades about 0.01 of its potential returns per unit of risk. MaxCyte is currently generating about -0.01 per unit of risk. If you would invest  5,916  in Inari Medical on September 2, 2024 and sell it today you would lose (724.00) from holding Inari Medical or give up 12.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inari Medical  vs.  MaxCyte

 Performance 
       Timeline  
Inari Medical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Inari Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal basic indicators, Inari Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point.
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Inari Medical and MaxCyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inari Medical and MaxCyte

The main advantage of trading using opposite Inari Medical and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inari Medical position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.
The idea behind Inari Medical and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories